Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform
Journal of Law, Medicine and Ethics, Vol. 40, p. 511, 2012
13 Pages Posted: 16 Oct 2012
Date Written: October 16, 2012
When physicians’ conflicts of interest arise from ties with drug firms, we should shift our focus to the pharmaceutical industry and improper dependencies that cause institutional corruption. This article analyzes eight forms of improper dependencies on pharma and proposes reforms.
Suggested Citation: Suggested Citation
Rodwin, Marc A., Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform (October 16, 2012). Journal of Law, Medicine and Ethics, Vol. 40, p. 511, 2012, Suffolk University Law School Research Paper No. 12-40, Available at SSRN: https://ssrn.com/abstract=2162597
Do you have a job opening that you would like to promote on SSRN?
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.